HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Filikov, A. V. Articles by Dahiyat, B. I. Search for Related Content PubMed PubMed Citation Articles by Filikov, A. V. Articles by Dahiyat, B. I. Social Bookmarking                   What's this?

Computational stabilization of human growth hormone

Xencor, Inc., Monrovia, California 91016, USA

Reprint requests to: Bassil I. Dahiyat, Xencor, Inc., 111 W. Lemon Avenue, Monrovia, CA 91016; e-mail: baz{at}xencor.com; fax: (626) 305-0350.

Recombinant human growth hormone (hGH) is used worldwide for the treatment of pediatric hypopituitary dwarfism and in children suffering from low levels of hGH. It has limited stability in solution, and because of poor oral absorption, is administered by injection, typically several times a week. Development has therefore focused on more stable or sustained-release formulations and alternatives to injectable delivery that would increase bioavailability and make it easier for patients to use. We redesigned hGH computationally to improve its thermostability. A more stable variant of hGH could have improved pharmacokinetics or enhanced shelf-life, or be more amenable to use in alternate delivery systems and formulations. The computational design was performed using a previously developed combinatorial optimization algorithm based on the dead-end elimination theorem. The algorithm uses an empirical free energy function for scoring designed sequences. This function was augmented with a term that accounts for the loss of backbone and side-chain conformational entropy. The weighting factors for this term, the electrostatic interaction term, and the polar hydrogen burial term were optimized by minimizing the number of mutations designed by the algorithm relative to wild-type. Forty-five residues in the core of the protein were selected for optimization with the modified potential function. The proteins designed using the developed scoring function contained six to 10 mutations, showed enhancement in the melting temperature of up to 16°C, and were biologically active in cell proliferation studies. These results show the utility of our free energy function in automated protein design.

Keywords: Protein design; free energy; entropy; human growth hormone; thermostability

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. M. van der Sloot, M. M. Mullally, G. Fernandez-Ballester, L. Serrano, and W. J. Quax Stabilization of TRAIL, an all-{beta}-sheet multimeric protein, using computational redesign Protein Eng. Des. Sel., September 1, 2004; 17(9): 673 - 680. [Abstract] [Full Text] [PDF]

				P. M. Steed, M. G. Tansey, J. Zalevsky, E. A. Zhukovsky, J. R. Desjarlais, D. E. Szymkowski, C. Abbott, D. Carmichael, C. Chan, L. Cherry, et al. Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants Science, September 26, 2003; 301(5641): 1895 - 1898. [Abstract] [Full Text] [PDF]

				R. J. Hayes, J. Bentzien, M. L. Ary, M. Y. Hwang, J. M. Jacinto, J. Vielmetter, A. Kundu, and B. I. Dahiyat Combining computational and experimental screening for rapid optimization of protein properties PNAS, December 10, 2002; 99(25): 15926 - 15931. [Abstract] [Full Text] [PDF]